GEN-XENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gen-xene, and what generic alternatives are available?
Gen-xene is a drug marketed by Alra and is included in three NDAs.
The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gen-xene
A generic version of GEN-XENE was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.
Summary for GEN-XENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 418 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GEN-XENE at DailyMed |
US Patents and Regulatory Information for GEN-XENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071787-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071788-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071789-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |